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Acid Sphingomyelinase Gene Knockout Ameliorates
Hyperhomocysteinemic Glomerular Injury in Mice
Lacking Cystathionine-b-Synthase
Krishna M. Boini, Min Xia, Justine M. Abais, Ming Xu, Cai-xia Li, Pin-Lan Li*
Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia, United States of America

Abstract
Acid sphingomyelinase (ASM) has been implicated in the development of hyperhomocysteinemia (hHcys)-induced
glomerular oxidative stress and injury. However, it remains unknown whether genetically engineering of ASM gene
produces beneficial or detrimental action on hHcys-induced glomerular injury. The present study generated and
characterized the mice lacking cystathionine b-synthase (Cbs) and Asm mouse gene by cross breeding Cbs+/2 and Asm+/2
mice. Given that the homozygotes of Cbs2/2/Asm2/2 mice could not survive for 3 weeks. Cbs+/2/Asm+/+, Cbs+/2/Asm+/2
and Cbs+/2/Asm2/2 as well as their Cbs wild type littermates were used to study the role of Asm2/2 under a background of
Cbs+/2 with hHcys. HPLC analysis revealed that plasma Hcys level was significantly elevated in Cbs heterozygous (Cbs+/2)
mice with different copies of Asm gene compared to Cbs+/+ mice with different Asm gene copies. Cbs+/2/Asm+/+ mice had
significantly increased renal Asm activity, ceramide production and O2.2 level compared to Cbs+/+/Asm+/+, while Cbs+/
2/
Asm2/2 mice showed significantly reduced renal Asm activity, ceramide production and O2.2 level due to increased
plasma Hcys levels. Confocal microscopy demonstrated that colocalization of podocin with ceramide was much lower in
Cbs+/2/Asm2/2 mice compared to Cbs+/2/Asm+/+ mice, which was accompanied by a reduced glomerular damage index,
albuminuria and proteinuria in Cbs+/2/Asm2/2 mice. Immunofluorescent analyses of the podocin, nephrin and desmin
expression also illustrated less podocyte damages in the glomeruli from Cbs+/2/Asm2/2 mice compared to Cbs+/2/Asm+/+
mice. In in vitro studies of podocytes, hHcys-enhanced O2.2 production, desmin expression, and ceramide production as
well as decreases in VEGF level and podocin expression in podocytes were substantially attenuated by prior treatment with
amitriptyline, an Asm inhibitor. In conclusion, Asm gene knockout or corresponding enzyme inhibition protects the
podocytes and glomeruli from hHcys-induced oxidative stress and injury.
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In recent studies, we and others have demonstrated that ASM
can be activated during hHcys whereby ceramide is produced to
result in activation of NADPH oxidase, local oxidative stress and
consequent glomerulosclerosis and loss of kidney functions [16–
19]. However, most of these studies were done using pharmacological or molecular interventions, but to our knowledge no
genetic approaches have been used to address the role of ASMceramide regulatory mechanism in the development of hHcysassociated glomerular injury or end-stage renal disease. Recently,
the characterization of Cbs gene knockout mice as one of the
hHcys model and development of Asm gene deletion in mice [20–
21] provide opportunity to address whether genetically manipulation of both genes can alter hHcys-induced pathological changes,
in particular in the renal glomeruli, which is a major focus of our
laboratory. In the present study, we hypothesized that genetically
engineering of Asm gene protects glomeruli from hHcys-induced
glomerular oxidative stress and thereby ameliorate podocyte injury
and glomerulosclerosis during hHcys. To test this hypothesis, we
for the first time generated the mice lacking Asm and Cbs gene
(lacking one alle of Cbs and two alle of Asm genes) to determine
whether Asm deletion has any affect on glomerular oxidative stress

Introduction
Acid sphingomyelinase (ASM), a ceramide producing enzyme
has been reported to be involved in the regulation of cell and
organ functions and has been implicated in the development of
different diseases such as obesity, diabetes, atherosclerosis, kidney
diseases and disorder of lipid metabolism [1–3]. ASM hydrolyzes
sphingomyelin to ceramide and phosphorylcholine and thereby
exerts its signaling or regulatory role. It has been reported that
ASM deficiency leads to Niemann-Pick disease in humans and
that Asm gene (Asm is commonly used to represent mouse gene for
ASM) knockout in mice resulted in the resistance to radiation [4]
and other forms of stress-induced apoptosis [1]. Similarly,
inhibition of ASM activity has also been shown to render cells
and animals resistant to the apoptotic effects of diverse stimuli
including Fas/CD95 [5], ischemia [6], radiation [7], chemotherapy [8] tumor necrosis factor-alpha (TNF-a) [9]. In addition, Asm
knockout or Asm inhibition was shown to have protective action
during the lung inflammation and fibrosis [10], cystic fibrosis [11–
12], obesity and associated glomerular injury [13], liver fibrogenesis [14] and renal fibrosis [15].
PLOS ONE | www.plosone.org
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and podocyte injury by hHcys that is occurred in Cbs gene
deficient mice. By analysis of Asm homozygous and heterozygous
mice with a background of Cbs partially deletion, we tried to
obtain gene titration data clarifying the pathogenic role in hHcys.
Using culture murine podocytes, we further examined the direct
effects of ASM inhibition on Hcys-induced cellular oxidative stress
and related injury. These in vivo and in vitro experiments elucidate
the role of ASM in the development of podocyte injury and
glomerular sclerosis associated with hHcys, which may identify an
important target for possible gene therapy during the course of
hHcys-induced pathology.

Results
Genotyping and Plasma Hcys Concentrations in DKO
Mice
The genotypes of the mutant mice were confirmed by PCR
using Cbs and Asm mouse gene specific primers. As shown in
Figure 1B, when Cbs gene primer was used for genotyping,
a 321 bp and 1500 bp product could be detected. Mice with only
a 321 bp band are wild type (Cbs+/+), while mice with two bands
are heterozygotes (Cbs+/2). In Asm genotyping, mice showing
a single product of 269 or 523 bp indicate Asm wild type (Asm+/+)
and homozygotes (Asm2/2), respectively. If both the two products
was detected in the same mice, these mice were heterozygotes of
Asm gene (Asm+/2). HPLC analyses showed that the plasma Hcys
concentrations was similar among Cbs+/+/Asm+/+, Cbs+/+/Asm+/
2
and Cbs+/+/Asm2/2 mice, which showed different Asm gene
types with the same background of Cbs wild type. Compared to
these Cbs wild type mice, the plasma Hcys concentrations were
significantly increased in Cbs heterozygotes with different Asm
gene copies, namely, Cbs+/2/Asm+/+, Cbs+/2/Asm+/2 and Cbs+/
2/
Asm2/2 mice, but there was no significant difference in plasma
Hcys levels in this group of mice with Cbs+/2 background with
different copies of Asm gene (Figure 1C). These data suggest that
Asm gene is not involved in the regulation of plasma Hcys levels
and therefore it does not alter the occurrence of hHcys in mice.
As illustrated in Figure 2A, the total renal ceramide levels were
substantially lower in Cbs+/+/Asm2/2 than Cbs+/+/Asm+/+ and
Cbs+/+/Asm+/2 mice. However, increased plasma Hcys level was
accompanied by significantly increased renal ceramide levels in
Cbs+/2/Asm+/+ mice, but not in Cbs+/2/Asm2/2 mice. Furthermore, confocal microscopic studies revealed that ceramide staining
was more pronounced in glomeruli of Cbs+/2/Asm+/+ mice than
in Cbs+/2/Asm2/2 mice (Figure 2B). In addition, using podocin
as a podocyte marker we showed that hHcys-induced ceramide
expression in glomeruli were mostly located in podocytes, as
demonstrated by the colocalization of ceramide with podocin. This
colocalization was substantially blocked in Cbs+/2/Asm2/2 mice
(Figure 2B). The Asm activity was significantly lower in Cbs+/+/
Asm2/2 compared to Cbs+/+/Asm+/+ mice, but it was significantly increased in Cbs+/2/Asm+/+ compared to Cbs+/+/Asm+/+
mice. However, this hHcys-induced Asm activity was significantly
attenuated in Cbs+/2/Asm2/2 mice (Figure 2C).

Figure 1. Genotyping and Plasma Hcys concentrations in Cbs+/
+
/Asm+/+, Cbs+/+/Asm+/2, Cbs+/+/Asm2/2, Cbs+/2/Asm+/+, Cbs +/
2/
Asm+/2 and Cbs+/2/Asm2/2 mice. A: Breeding scheme used to
generate Cbs+/+/Asm+/+, Cbs+/+/Asm+/2, Cbs+/+/Asm2/2, Cbs+/2/Asm+/+,
Cbs+/2/Asm+/2 and Cbs+/2/Asm2/2 mice. B: Genotyping in mutant
mice. Two PCR products suggest that heterozygous mutation, while
single band represents wild type or knockout allele. C: Values are
arithmetic means 6 SE (n = 6 each group) of plasma Hcys concentrations in Cbs+/+/Asm+/+, Cbs+/+/Asm+/2, Cbs+/+/Asm2/2, Cbs+/2/Asm+/+,
Cbs+/2/Asm+/2 and Cbs+/2/Asm2/2 mice. * Significant difference
(P,0.05) compared to the values from Cbs+/+/Asm+/+ mice; # Significant
difference (P,0.05) compared to the values from Cbs+/2/Asm+/+ mice.
doi:10.1371/journal.pone.0045020.g001

mice such as glomerular capillary collapse and mesangial
expansion. This pathology was not observed in Cbs+/2/Asm2/2
mice. The average glomerular damage index (GDI) was significantly higher in Cbs+/2/Asm+/+ mice than in Cbs+/2/Asm2/2
mice (Figure 3C and 3D).
Further, we determined whether protective effect of Cbs+/
2/
Asm2/2 gene knockout is associated with the protection of
podocytes in hHcys-induced glomerular injury. As shown in
Figure 4A, the immunofluorescent analysis showed that desmin
staining was more pronounced in glomeruli of Cbs+/2/Asm+/+
than Cbs+/+/Asm+/+ and Cbs+/+/Asm+/2 mice, as shown by

Attenuation of hHcys-induced Glomerular Injury in Cbs+/
2
by Further Knockout of Asm Gene
As depicted in Figure 3A and 3B, urinary protein and albumin
excretion was similar in Cbs+/+/Asm+/+, Cbs+/+/Asm+/2 and
Cbs+/+/Asm2/2 mice. However, the urinary total protein and
albumin excretion increased significantly in Cbs+/2/Asm+/+ mice,
but not in Cbs+/2/Asm2/2 mice, despite that both mouse strains
have hHcys. By PAS staining, we observed a typical pathological
change showing glomerular sclerotic damage in Cbs+/2/Asm+/+
PLOS ONE | www.plosone.org
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Figure 2. Renal tissue ceramide production and Asm activity in Cbs+/+/Asm+/+, Cbs+/+/Asm+/2, Cbs+/+/Asm2/2, Cbs+/2/Asm+/+, Cbs+/
2/
Asm+/2 and Cbs+/2/Asm2/2 mice. Values are arithmetic means 6 SE (n = 6 each group) of total ceramide concentrations (A), ceramide
production (B) and Asm activity (C) in Cbs+/+/Asm+/+, Cbs+/+/Asm+/2, Cbs+/+/Asm2/2, Cbs+/2/Asm+/+, Cbs+/2/Asm+/2 and Cbs+/2/Asm2/2 mice. The
AOI shows the higher magnification of boxed area in overlaid images in panel B. AOI: Area of interest. * Significant difference (P,0.05) compared to
the values from Cbs+/+/Asm+/+ mice; # Significant difference (P,0.05) compared to the values from Cbs+/2/Asm+/+ mice.
doi:10.1371/journal.pone.0045020.g002

demonstrated that desmin protein expression was significantly
increased in Cbs+/2/Asm+/+ mice compared to Cbs+/+/Asm+/+.
However, the enhanced desmin expression was attenuated in
Cbs+/2/Asm2/2 mice (Figure 4B and 4C).

more remarkable red fluorescence detected in glomeruli, which
indicates podocytes injury. However in Cbs+/2/Asm2/2 mice the
hHcys-induced increase in desmin expression within glomeruli of
mice was not observed (Figure 4A). In contrast, other podocyte
markers podocin and nephrin staining were found markedly
reduced in glomeruli of Cbs+/2/Asm+/+ mice compared to Cbs+/
+
/Asm+/+ and Cbs+/+/Asm+/2 mice, and in Cbs+/2/Asm2/2
mice this reduced podocin and nephrin expression or production
were not observed (Figure 4A). In addition, Western blot analysis

PLOS ONE | www.plosone.org

Lack of Local Oxidative Stress in the Glomeruli of Cbs+/
2/
Asm2/2 Mice with hHcys
As illustrated in Figure 5A, the ESR spectrometric curve
exhibited significant increase in the amplitude of Nox-dependent
3
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Figure 3. Glomerular injury in Cbs+/+/Asm+/+, Cbs+/+/Asm+/2, Cbs+/+/Asm2/2, Cbs+/2/Asm+/+, Cbs+/2/Asm+/2 and Cbs+/2/Asm2/2 mice.
A: Values are arithmetic means 6 SEM (n = 6 each group) of urinary total protein excretion, B: Urinary albumin excretion in Cbs+/+/Asm+/+, Cbs+/+/
Asm+/2, Cbs+/+/Asm2/2, Cbs+/2/Asm+/+, Cbs+/2/Asm+/2 and Cbs+/2/Asm2/2 mice. C: Photomicrographs show typical glomerular structure (original
magnification, x400) in Cbs+/+/Asm+/+, Cbs+/+/Asm+/2, Cbs+/+/Asm2/2, Cbs+/2/Asm+/+, Cbs+/2/Asm+/2 and Cbs+/2/Asm2/2 mice. D: Summarized data
of glomerular damage index (GDI) by semi-quantitation of scores in 6 different groups of mice (n = 6 each group). For each kidney section, 50
glomeruli were randomly chosen for the calculation of GDI. * Significant difference (P,0.05) compared to the values from Cbs+/+/Asm+/+ mice; #
Significant difference (P,0.05) compared to the values from Cbs+/2/Asm+/+ mice.
doi:10.1371/journal.pone.0045020.g003

ESR O2.2 signals in the glomeruli of Cbs+/2/Asm+/+ mice
compared to mice with Cbs+/+ background and different copies of
Asm genes. However, this enhanced glomerular O2.2 production
in Cbs+/2/Asm+/+ mice was not observed in Cbs+/2/Asm2/2
mice. These results were summarized in Figure 5B, showing that
glomerular O2.2 production was similar in all Cbs+/+ mice with
different Asm gene copies, but it was increased by 3.1 folds in
Cbs+/2/Asm+/+ mice compared to those mice with Cbs+/+ and
different Asm gene copies. This hHcys-induced glomerular O2.2
level enhanced in Cbs+/2/Asm+/+ mice were attenuated in Cbs+/
2/
Asm2/2 mice.

cultured murine podocytes, we examined ceramide production
and related expression of podocyte markers. As shown in Figure 6,
immunofluorescent analysis demonstrated that Hcys stimulation
increased the desmin and ceramide expression in podocytes
compared to untreated cells. Prior treatment with Asm inhibitor,
amitriptyline decreased Hcys-induced elevation of desmin and
ceramide production in podocytes (Figure 6A). Another podocyte
marker, however, podocin was markedly reduced upon Hcys
stimulation in podocytes, and the Asm inhibition almost
completely attenuated the decrease in podocin expression
(Figure 6A). The summarized data were shown in Figure 6B.

Blockade of Hcys-induced Ceramide Expression and
Podocyte Injury by Asm Inhibition in Cultured Podocytes

Blockade of Hcys-induced Oxidative Stress and Decrease
in VEGF-A Secretion by Asm Inhibition

The above studies demonstrated that mice lacking Cbs and Asm
gene protect glomerular oxidative stress, injury and podocyte
injury. We further performed some in vitro experiments to confirm
whether glomerular injury truly occurs in podocytes. Using

As depicted in Figure 7A, the O2.2 production was similar in
both control and amitriptyline-treated podocytes. However, the
Hcys stimulation significantly increased the O2.2 production by
1.9 folds compared to control cells, but prior treatment with

PLOS ONE | www.plosone.org
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Figure 4. Immunofluorescent staining of anti-desmin, anti-podocin and anti-nephrin antibody in glomeruli of Cbs+/+/Asm+/+, Cbs+/+/
Asm+/2, Cbs+/+/Asm2/2, Cbs+/2/Asm+/+, Cbs+/2/Asm+/2 and Cbs+/2/Asm2/2 mice. A: Typical images of desmin, podocin and nephrin staining
in glomeruli from Cbs+/+/Asm+/+, Cbs+/+/Asm+/2, Cbs+/+/Asm2/2, Cbs+/2/Asm+/+, Cbs+/2/Asm+/2 and Cbs+/2/Asm2/2 mice (n = 6 each group). B:
Western blot analysis of desmin protein expression in different groups of mice. C: Summarized data showing the quantification of desmin expression,
which was normalized to b-actin (n = 6). * Significant difference (P,0.05) compared to the values from Cbs+/+/Asm+/+ mice; # Significant difference
(P,0.05) compared to the values from Cbs+/2/Asm+/+ mice.
doi:10.1371/journal.pone.0045020.g004

amitriptyline significantly attenuated the Hcys-induced O2.2
production (Figure 7A). As a functional parameter of podocytes,
VEGF-A production was detected in podocytes under various
conditions. It was found that VEGF-A production and secretion
were dramatically decreased by L-Hcys treatment compared to
control cells. However, pretreatment of podocytes with amitriptyline significantly attenuated the Hcys-induced VEGF-A secrePLOS ONE | www.plosone.org

tion. PAN is served a positive control (Figure 7B). Furthermore, we
also performed the immunofluorescent experiments using rhodamine-phalloidin as a dye for F-actin, it was found that Hcys
treatment induced dramatic reorganization and disruption of the
F-actin cytoskeleton in podocytes compared to control cells.
However, pretreatment of podocytes with amitriptyline attenuated
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Figure 5. Glomerular O2.2 production in Cbs+/+/Asm+/+, Cbs+/+/Asm+/2, Cbs+/+/Asm2/2, Cbs+/2/Asm+/+, Cbs+/2/Asm+/2 and Cbs+/
2/
Asm2/2 mice. A: Representative ESR spectra traces for O2.2 production in 6 different groups of mice. B: Values are arithmetic means 6 SEM (n = 5
each group) of O2.2 production in Cbs+/+/Asm+/+, Cbs+/+/Asm+/2, Cbs+/+/Asm2/2, Cbs+/2/Asm+/+, Cbs+/2/Asm+/2 and Cbs+/2/Asm2/2. * Significant
difference (P,0.05) compared to the values from Cbs+/+/Asm+/+ mice; # Significant difference (P,0.05) compared to the values from Cbs+/2/Asm+/+
mice.
doi:10.1371/journal.pone.0045020.g005

gene by cross breeding Cbs+/2 and Asm+/2 mice. Given that the
homozygotes of Cbs2/2/Asm2/2 mice could not survive for 3
weeks, Cbs+/2/Asm+/+, Cbs+/2/Asm+/2 and Cbs+/2/Asm2/2 as
well as their Cbs wild type littermates were used to study the role
of Asm2/2 under a background of Cbs+/2 that produced hHcys.
Previous studies have shown that Hcys levels in the blood are
a complex trait that is affected by several genetic and environmental factors. It is known that genetic factors contribute to mild,
moderate [22] and severe hHcys [23], and that the genetic
background is the specific collection of allelic gene variants that
make individuals to present different inheritable characters within
species. In this sense, inbred mouse strains are widely used to study
the effects of different genetic background on the disease
phenotype [24]. In the present study, we tested the role of Asm
gene in the development of hHcys-induced glomerular injury or
sclerosis by using Cbs+/2 mutant mice. These mice have 50%
reduction in Cbs mRNA and enzyme activity in the liver and have
a normal plasma Hcys levels by 2 folds higher than that in wild
type littermates [19,25]. Thus, the Cbs+/2 mice may develop mild

the Hcys-induced disruption of F-actin cytoskeleton in podocytes
and were restored to normal (Figure 7C and 7D).

Discussion
The major goal of the present study is to determine whether
genetically engineering of acid sphingomyelinase (Asm) produces
beneficial or detrimental effects in the development of hHcysinduced glomerular injury and sclerosis. We found that the genetic
model of hyperhomocysteinemic Cbs mice (Cbs+/2/Asm+/+)
enhanced the ceramide production and Asm activity, which was
attributed to NADPH oxidase dependent O2.2 production and
local oxidative stress in glomeruli and ultimately led to podocyte
injury and glomerulosclerosis. These results demonstrate for the
first time that mice lacking Cbs and Asm gene (Cbs+/2/Asm2/2)
protect against the hHcys-induced glomerular oxidative stress and
injury in mice.
We first generated and characterized the mice lacking
cystathionine b-synthase (Cbs) and acid sphingomyelinase (Asm)

PLOS ONE | www.plosone.org
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Figure 6. Production of ceramide, podocin and desmin staining in podocytes with or without Hcys and/or amitriptyline treatment.
Cultured podocytes were treated with or without Hcys for 24 h. A: Typical fluorescent microscopic images of ceramide, podocin and desmin in Hcys
and/or amitriptyline treated podocytes (n = 5/group, Original magnification, 6400). B: Values are arithmetic means 6 SE (n = 5 each group) of
summarized data showing the percentage of positive staining cells of ceramide, desmin and podocin vs. control group. Ctrl: Control, Hcy:
Homocysteine, Ami: Amitriptyline. * Significant difference (P,0.05) compared to the control group; # Significant difference (P,0.05) compared to the
Hcys group.
doi:10.1371/journal.pone.0045020.g006
2/
Asm+/2 and Cbs+/2/Asm2/2 mice compared to their Cbs wild
type littermates. These results suggest that Asm itself is not
involved in the metabolism of Hcys. Importantly, we found that

hHcys and are a good model to study the hHcys-related disease
processes [19]. Indeed, our results showed that plasma Hcys
concentration was two fold higher in all Cbs+/2/Asm+/+, Cbs+/

PLOS ONE | www.plosone.org
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Figure 7. O2. – production and VEGF levels in podocytes with or without Hcys and/or amitriptyline treatment. Cultured podocytes
were treated with or without Hcys for 24 h. Values are arithmetic means 6 SE (n = 5 each group) of O2.2 production (A), VEGF levels (B) in podocytes
with or without Hcys and/or amitriptyline treatment. C. Representative microscopic images showing F-actin staining in podocytes using rhodaminephalloidin staining (magnification, 6400). D. Summarized data showing the rate of podocytes retaining distinct longitudinal stress fibers. Scoring was
from 100 podocytes on each slide in different groups (n = 5 each group). Ctrl: Control, Hcy: Homocysteine, Ami: Amitriptyline, Veh: Vehicle. *
Significant difference (P,0.05) compared to the control group; # Significant difference (P,0.05) compared to the Hcys group.
doi:10.1371/journal.pone.0045020.g007

stress and glomerular injury in mice lacking Cbs gene (Cbs+/
Asm2/2).
Using podocin as a podocytes marker, our confocal microscopic
data showed that hHcys-induced ceramide expression in glomeruli
was mostly located in podocytes, as demonstrated by the
colocalization of ceramide with podocin. This colocalization was
substantially blocked in mice lacking both Asm and Cbs gene
(Cbs+/2/Asm2/2). Furthermore, Asm activity in renal tissues were
significantly increased in hyperhomocysteinemic Cbs+/2/Asm+/+
mice, but not in Cbs+/2/Asm2/2. The increased Asm activity in
Cbs+/2/Asm+/+ mice may at least be partially due to the
enhancement of Asm mRNA expression. In this regard, our
previous studies have shown that hHcys increased the Asm activity
and Asm mRNA expression in renal tissues of Asm+/+ mice but
not in Asm2/2 mice [21]. It was also shown that Hcys stimulation
in podocytes enhanced the co-localization of membrane raft and
Asm in the plasma membrane and revealed the translocation of
Asm into cell membrane upon Hcys treatment [21]. These results
suggest that hHcys-induced renal and glomerular ceramide
production is mainly caused by activation of Asm in mice. In
accordance with lowered ceramide production in Cbs+/2/Asm2/2
mice, urinary albumin, protein excretion and glomerular injury
and sclerosis were also significantly decreased compared with
Cbs+/2/Asm+/+ mice, suggesting that ceramide-associated renal
injury during hHcys is alleviated in these Cbs+/2/Asm2/2. Taken
together, these results suggest that Asm gene knockout produces
the beneficial effects in hyperhomocysteinemic mice that lack Cbs
gene and therefore Asm gene and corresponding signaling

the increased plasma Hcys concentration resulted in a remarkable
glomerular damage or sclerosis in Cbs+/2/Asm+/+ mice, but not in
Cbs+/2/Asm2/2 mice, suggesting that Asm gene knocking out
prevents glomeruli from hHcys-induced injury in mice with fewer
copies of Cbs genes.
There is considerable evidence supporting the critical role of
ceramide signaling pathway in the pathogenesis of kidney diseases
[18,21]. Ceramide production is mainly mediated via the
hydrolysis of membrane sphingomyelin by various sphingomyelinases such as acid sphingomyelinase (Asm) or neutral sphingomyelinase (NSM) or by de novo synthesis via serine palmitoyltransferase (SPT) and ceramide synthase [26]. It is subsequently
metabolized into sphingosine by ceramidases, and sphingosine can
be further converted to S1P via sphingosine kinase [26] in
response to a variety of stimuli including proinflammatory
cytokines, oxidative stress, and increased levels of free fatty acids.
It has been reported that ceramide may mediate the detrimental or
pathogenic actions induced by many different injury factors in
different cells and tissues [27–29]. More recently, ceramidemediated signaling has been found to cross talk with redox
signaling associated with NAD(P)H oxidase, which represents
a novel cellular signaling cascade that participates in the development of different diseases [18,21]. In this regard, we recently
reported that increased plasma Hcys concentrations enhanced the
ceramide production leading to activation of NAD(P)H oxidase in
the kidney and that inhibition of ceramide production improved
glomerular injury in those hyperhomocysteinemic rats [18]. The
present study further demonstrated that Asm gene knockout
attenuated hHcys-induced ceramide production, local oxidative
PLOS ONE | www.plosone.org

2/

8

September 2012 | Volume 7 | Issue 9 | e45020

Cbs and Asm Genes in Hcy Induced Glomerular Injury

pathway could be a therapeutic target for hHcys-induced podocyte
injury and consequent glomerular sclerosis.
To further explore the mechanisms by which Asm gene
knockout protects glomeruli from injury induced by hHcys, we
observed more changes in podocyte function in various gene
mutant mice. It has been well documented that proteinuria is
a hallmark of renal injury and a major deteriorating factor for
progression of end-stage renal diseases [30]. The outer aspect of
glomerular basement membrane is lined up with very specialized
visceral epithelial cells, named podocytes, and these podocytes
serve as the final defense against urinary protein loss in the normal
glomerulus [31]. Any damage to these podocytes and their slit
diaphragm is intimately associated with proteinuria [32]. The
assessment of normal slit diaphragm component such as podocin
[33] and injured podocyte marker, desmin [34] are now therefore
considered as two major sensitive markers of podocyte injury and
subsequently glomerulopathy in renal diseases. In the present
study, we showed that podocin and nephrin proteins were
markedly decreased in hyperhomocysteinemic Cbs+/2/Asm+/+
mice, but not in mice lacking both Asm and Cbs gene (Cbs+/
2/
Asm2/2). In addition, we found that desmin was markedly
increased in the glomeruli of Cbs+/2/Asm+/+ mice compared to
Cbs+/2/Asm2/2 mice. These results further support the view that
hHcys-induced glomerular injury is associated with increased
ceramide production via Asm and its pathological action on
podocytes. Furthermore, several studies have demonstrated that
NADPH oxidase-dependent O2.2 production is an early event for
Hcys-induced glomerular cell damage and glomerular sclerosis
[18,35]. It is possible that hHcys-induced NADPH oxidase
activation is mediated by enhanced Asm activity in Cbs+/
2/
Asm+/+ mice. To test this hypothesis, the present study
demonstrated by electron spin resonance analysis that hHcys
indeed significantly increased NADPH oxidase-dependent O2.2
production in Cbs+/2/Asm+/+ mice, but not in Cbs+/2/Asm2/2
mice. These results support the view that Asm gene expression and
ceramide production play a critical role in mediating glomerular
O2.2 production through activation of NADPH oxidase during
hHcys.
In addition to the whole animal experiments, we also used
cultured murine podocytes to examine the direct effect of altered
ASM activity on ceramide production and podocyte injury, which
attempted to further confirm the role of ceramide and consequent
NADPH oxidase activation in Hcys-induced podocyte injury. It
was found that Hcys stimulation in mouse podocytes significantly
increased the ceramide and desmin expression, but decreased the
podocin expression compared to control cell group. However,
pretreatment with amitriptyline, an Asm inhibitor attenuated the
Hcys-induced ceramide production and podocyte injury. Furthermore, we examined whether the effects of ASM inhibition are
associated with Hcys-enhanced oxidative stress in podocytes. It
was found that amitriptyline blocked Hcys-induced NADPH
oxidase activation. Given that ceramide production is a critical
early mechanism initiating or promoting Hcys-induced podocyte
injury and glomerulosclerosis [36], these results from cultured
mouse podocytes further confirm the findings from our in vivo
studies, supporting a conclusion that Hcys-induced podocyte and
glomerular injury is associated with increased ceramide production via ASM activity. Another functional abnormality of
Hcys-induced podocyte injury was detected in the present study,
namely, the production of VEGF-A in cultured podocytes.
Podocyte-derived VEGF-A is found to be decreased in sclerotic
glomeruli [37], while treatment with exogenous VEGF-A
decreases renal sclerotic injuries and restores glomerular capillaries
[38]. VEGF-A may serve as a crucial growth factor in maintaining
PLOS ONE | www.plosone.org

the normal function of podocytes by preventing their apoptosis
through the interaction with nephrin and activation of AKT
signaling pathway [39]. In the present study, we found that Hcys
treatment significantly decreased the production of VEGF-A in
podocytes, which was restored by amitriptyline, an ASM inhibitor.
In summary, the present study demonstrated that mice lacking
Asm gene produced beneficial effects on glomerular injury and
sclerosis occurred in mice lacking Cbs gene with hHcys. This
amelioration of glomerular injury by Asm gene knockout or ASM
inhibition during hHcys suggests the pivotal role of Asm gene
expression and ASM activation in hHcys-induced glomerulosclerosis. These findings may potentially direct towards the
development of new therapeutic strategies for treatment and
prevention of end-stage renal disease associated with hHcys and
hHcys-related pathological processes such as hypertension, diabetes, atherosclerosis, and aging.

Materials and Methods
Animals and Genotyping of Mice
Cbs+/2 and wild-type mice were purchased from the Jackson
Laboratory. We first generated and characterized the mice lacking
cystathionine b-synthase (Cbs) and Asm gene by cross breeding
Cbs+/2 and Asm+/2 mice after each of original mouse strains was
bred more than 5 generations with careful genotyping to maximize
their purity (Figure 1A). Twelve weeks old male uninephrectomized Cbs+/+/Asm+/+, Cbs++/Asm+/2, Cbs+/+/Asm2/2, Cbs+/
2/
Asm+/+, Cbs+/2/Asm+/2, Cbs+/2/Asm2/2 were used in the
present study. In Cbs2/2 homozygous mice [40], a genomic
fragment of exons 2 and 3, which encodes Cbs putative active site,
was replaced by a neomycin selection cassette. PCR confirmation
of this genotype was achieved by specific primers designed for
wild-type extron 2, 59-TCTGAGGACCAATGTTAGGATG-39
and 59-CTAATGGAACTTCGCCTTGTG-39. For confirmation
of Asm gene deletion [41] in these mice, primers 59CTTGGGTGGAGAGGCTATTC-39 and 59-AGGTGAGATGACAGGAGATC-39 were used for genotyping. The genomic
DNA was extracted from the mouse tails using the ArchivePure
DNA purification kit (5 Prime Inc., Gaithersburg, MD), and the
PCR reaction was carried out in a Bio-Rad iCycler, initiated at
94uC for 1 min to denature the template and activate the Taq
DNA polymerase, followed by 30 cycles of PCR amplification.
Each cycle included denaturing at 94uC for 30s, annealing at 55uC
for 30s, and extension at 72uC for 1 min. The electrophoresis of
PCR products was performed in 2% agarose gel. All protocols
were approved by the Institutional Animal Care and Use
Committee of the Virginia Commonwealth University.

High-performance Liquid Chromatography (HPLC)
Analysis
Plasma Hcys levels were measured by HPLC method as we
described previously [21,42]. A 100 mL plasma or standard
solution mixed with 10 mL of internal standard, thionglycolic acid
(2.0 mmol/L) solution, was treated with 10 mL of 10% tri-nbutylphosphine (TBP) solution in dimethylformamide at 4uC for
30 minutes. Then, 80 mL of ice-cold 10% trichloro acetic acid
(TCA) in 1 mmol/L EDTA was added and centrifuged to remove
proteins in the sample. 100 mL of the supernatant was transferred
into the mixture of 20 mL of 1.55 mol/L sodium hydroxide,
250 mL of 0.125 mol/L borate buffer (pH 9.5), and 100 mL of
1.0 mg/mL ABD-F solution. The resulting mixture was incubated
at 60uC for 30 minutes to accomplish derivatization of thiols.
HPLC was performed with a HP 1100 series instrument (Agilent
Technologies, Waldbronn, Germany) equipped with a binary
9
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pump, a vacuum degasser, a thermo stated column compartment,
and an auto sampler (Agilent Technologies, Waldbronn, Germany). Separation was carried out at an ambient temperature on
an analytical column, Supelco LC-18-DB (Supelco; 15064.6 mm
i.d., 5 mm particle size) with a Supelcosil LC-18 guard column
(Supelco; 2064.6 mm i.d., 5 mm particle size). Fluorescence
intensities were measured with an excitation wavelength of
385 nm and emission wavelength of 515 nm by a HewlettPackard Model 1046A fluorescence detector (Agilent Technologies). The peak area of the chromatographs was quantified with
a Hewlett-Packard 3392 integrator (Agilent Technologies). The
analytical column was eluted with 0.1 mol/L potassium dihydrogen phosphate buffer (pH 2.1) containing 6% acetonitrile (v/v) as
the mobile phase with a flow rate of 2.0 mL/min.

MassLynx 3.5 and configured with a Z-spray electrospray
ionization source. Source conditions were same as described
previously in our studies and by others [21,45].

Cell Culture
Conditionally immortalized mouse podocyte cell line [46],
kindly provided by Dr. Klotman PE (Division of Nephrology,
Department of Medicine, Mount Sinai School of Medicine, New
York, NY, USA), was cultured on collagen I-coated flasks or plates
in RPMI 1640 medium supplemented with recombinant mouse
interferon–c at 33uC. After differentiated at 37uC for 10–14 days
without interferon–c, podocytes were used for the proposed
experiments as we described previously [21].

Indirect Immuno-fluorescent Staining

Morphological Examinations

Podocytes were grown on poly-L-lysine–coated chambers and
treated with Hcys (40 mM, 24 hrs). In additional group of cells, the
Asm inhibitor, amitriptyline (20 mM, Sigma, St. Louis, MO, USA)
was added to pretreat the cells for 30 minutes before the addition
of Hcys. The cells were fixed in 4% PFA for 15 minutes. After
rinsed with phosphate-buffer saline (PBS), cells were incubated
with anti-podocin (Sigma, St. Louis, MO, USA, 1: 100), antidesmin (BD Biosciences, San Jose, CA, 1: 100), or anti-ceramide
(Enzo Life Sciences, Plymouth Meeting, PA, 1:200) antibodies.
After washing, the slides were incubated with Alexa 555-labeled
secondary antibodies for 1 h at room temperature. After being
mounted with DAPI-containing mounting solution, the slides were
observed under a fluorescence microscope and photos were taken
and analyzed. The fluorescent intensities were quantified by the
Image Pro Plus 6.0 software (Media Cybernetics, Bethesda, MD,
USA) and the data was normalized to control cells.

The fixed kidneys were paraffin-embedded, and sections were
prepared and stained with Periodic acid–Schiff stain. Glomerular
damage index (GDI) was calculated from 0 to 4 on the basis of the
degree of glomerulosclerosis and mesangial matrix expansion as
described previously [43]. In general, we counted 50 glomeruli in
total in each kidney slide under microscope, when each glomerulus
was graded level 0–4 damages. 0 represents no lesion, 1+
represents sclerosis of ,25% of the glomerulus, while 2+, 3+,
and 4+ represent sclerosis of 25% to 50%, .50% to 75%, and
.75% of the glomerulus. A whole kidney average sclerosis index
was obtained by averaging scores from counted glomeruli [44].
This observation was conducted by two independent investigators
who were blinded to the treatment of experimental animal groups.

Asm Activity
The activity of Asm was determined as we described previously
[13,21]. Briefly, N-methyl-[14C]-sphingomyelin was incubated
with renal cortical tissue homogenates, and the metabolites of
sphingomyelin, [14C]-choline phosphate was quantified. An
aliquot of homogenates (20 mg) was mixed with 0.02 mCi of Nmethyl 14C-sphingomyelin in 100 ml acidic reaction buffer
containing 100 mmol/L sodium acetate, and 0.1% Triton X100, pH 5.0, and incubated at 37uC for 15 min. The reaction was
terminated by adding 1.5 ml chloroform:methanol (2:1) and
0.2 ml double-distilled water. The samples were then vortexed
and centrifuged at 1,000 g for 5 min to separate into two phases. A
portion of the upper aqueous phase containing 14C-choline
phosphate was transferred to scintillation vials and counted in
a Beckman liquid scintillation counter. The choline phosphate
formation rate (nmol?min–1?mg protein–1) was calculated to
represent the enzyme activity.

Western Blot Analysis
Western blot analysis was performed as we described previously
[36]. In brief, proteins from the mouse renal cortex were extracted
using sucrose buffer containing protease inhibitor. After boiled for
5 min at 95uC in a 56 loading buffer, 20 mg of total proteins were
subjected to SDS-PAGE, transferred onto a PVDF membrane and
blocked. Then, the membrane was probed with primary antibody
of anti-desmin (1:500, BD Biosciences, San Jose, CA, USA) or
anti-b-actin (1:3000, Santa Cruz Biotechnology, Santa Cruz, CA,
USA) overnight at 4uC followed by incubation with horseradish
peroxidase-labeled IgG (1:5000). The immuno-reactive bands
were detected by chemiluminescence methods and visualized on
Kodak Omat X-ray films. Densitometric analysis of the images
obtained from X-ray films was performed using the Image J
software (NIH, Bethesda, MD, USA).

Liquid Chromatography–electrospray Ionization Tandem
Mass Spectrometry (LC-ESI-MS) for Quantitation of
Ceramide

Direct Fluorescent Staining of F-actin
To determine the role of ASM inhibition in Hcys-induced
cytoskeleton changes, podocytes were cultured in 8-well chambers
and treated with Hcys (40 mM, 24 hrs). In additional group of
cells, the Asm inhibitor, amitriptyline (20 mM, Sigma, St. Louis,
MO, USA), was added to pretreat the cells for 30 minutes before
the addition of Hcys or puromycin aminonucleoside (PAN,
100 mg/ml, Sigma, St. Louis, MO, USA) for 24 h. After
pretreatment with vehicle, amitriptyline, the cells were treated
with L-Hcys (40 mM) for 24 h. After washing with PBS, the cells
were fixed in 4% paraformaldehyde for 15 min at room
temperature, permeabilized with 0.1% Triton X-100, and blocked
with 3% bovine serum albumin. F-actin was stained with
rhodamine-phalloidin (Invitrogen, Carlsbad, CA, USA) for
15 min at room temperature. After mounting, the slides were

Separation, identification and quantitation of ceramide in
plasma were performed by LC/MS. The HPLC equipped with
a binary pump, a vacuum degasser, a thermostated column
compartment and an autosampler (Waters, Milford, MA, USA).
The HPLC separations were performed at 70uC on a RP C18
Nucleosil AB column (5 mm, 70 mm62 mm i.d.) from Macherey
Nagel (Duren, Germany). The mobile phase was a gradient
mixture formed as described [45]. The renal lipids were extracted
according to previous studies. To avoid any loss of lipids, the
whole procedure was performed in siliconized glassware. MS
detection was carried out using a Quattro II quadrupole mass
spectrometer (Micromass, Altrincham, England) operating under
PLOS ONE | www.plosone.org
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examined by a confocal laser scanning microscope. Cells with
distinct F-actin fibers were counted as we described previously
[36]. Scoring was obtained from 100 podocytes on each slide in
different groups.

Double-immunofluorescent Staining
Double-immunofluorescent staining was performed using
frozen slides from mouse kidneys. After fixation, the slides were
incubated with rabbit anti-podocin antibody at 1:100 (Sigma,
St. Louis, MO, USA), which was followed by incubation with
Alexa 488-labeled goat anti-rabbit secondary antibody. Then,
mouse anti-ceramide antibody (Enzo Life Sciences, Plymouth
Meeting, PA, 1:50) was used to incubate with the slides
overnight at 4uC. After washing, the slides were incubated with
corresponding Alexa 555-labeled secondary antibodies. Finally,
the slides were mounted and subjected to examinations using
a confocal laser scanning microscope (Fluoview FV1000,
Olympus, Japan). All exposure settings were kept constant for
each group of kidneys.

ELISA for Vascular Endothelial Growth Factor A (VEGF-A)
in Podocytes
After pretreatment with amitriptyline (20 mM, Sigma, St. Louis,
MO, USA), and its vehicle, podocytes were incubated with Hcys
(40 mM) for 24 h. A specific podocyte injury compound,
puromycin aminonucleoside (PAN, 100 mg/ml) was used to treat
cells for 24 h to serve as a positive control. The supernatant was
collected for ELISA assay of VEGF-A using a commercially
available kit (R&D system, Minneapolis, MN).

Urinary Total Protein and Albumin Excretion
Measurements

Immunofluorescent Staining
Immunofluorescent staining was performed using frozen slides
of mouse kidneys. After fixation with acetone, the slides were
incubated with anti-podocin (Sigma, St. Louis, MO, USA, 1:100),
anti-desmin (BD Biosciences, San Jose, CA, 1:50), anti-nephrin
(Abcam, Cambridge, MA, 1:50), antibodies overnight at 4uC.
Then, these slides were washed and incubated with corresponding
Texas Red-labeled secondary antibodies. Finally, the slides were
washed, mounted and subjected to fluorescent microscopic
examination. The images were captured with a spot CCD camera
and a pseudocolor was added to corresponding fluorescent image
(Diagnostic Instruments Inc., Sterlin Heights, MI, USA). All
exposure settings were kept constant for each group of kidneys.

The 24-hour urine samples were collected using metabolic cages
and subjected to total protein and albumin excretion measurements, respectively [13,21]. Total protein content in the urine was
detected by Bradford method using a UV spectrophotometer.
Urine albumin was detected using a commercially available
albumin ELISA kit (Bethyl Laboratories, Montgomery, TX).

Electronic Spin Resonance (ESR) Analysis of O2.2
Production
For detection of Nox-dependent O2.2 production, proteins
from the renal cortex and cultured podocytes were extracted using
sucrose buffer and resuspended with modified Kreb’s–Hepes
buffer containing deferoximine (100 mM, Sigma) and diethyldithiocarbamate (5 mM, Sigma). The NADPH oxidase-dependent
O2.2 production was examined by addition of 1 mM NADPH as
a substrate in 50 mg protein and incubated for 15 min at 37uC in
the presence or absence of SOD (200 U/ml), and then supplied
with 1 mM O2.2 specific spin trapping substance, 1-hydroxy-3methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine (CMH, Noxygen, Elzach, Germany). The mixture was loaded in glass
capillaries and immediately analyzed for O2.2 production
kinetically for 10 min in a Miniscope MS200 electromagnetic
spin resonance (ESR) spectrometer (Magnettech Ltd, Berlin,
Germany). The ESR settings were as follows: biofield, 3350; field
sweep, 60 G; microwave frequency, 9.78 GHz; microwave power,
20 mW; modulation amplitude, 3 G; 4,096 points of resolution;
receiver gain, 20 for tissue and 50 for cells. The results were
expressed as the fold changes of control.

Statistical Analysis
Data are provided as arithmetic means 6 SEM; n represents the
number of independent experiments. All data were tested for
significance using ANOVA for data obtained from multiple
animal or experimental groups or paired and unpaired Student’s ttest for two groups of animals or experimental protocols. The
glomerular damage index was analysed for statistic significance
using a nonparametric Mann-Whitney rank sum test. Only results
with p,0.05 were considered statistically significant.
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